127 related articles for article (PubMed ID: 25503724)
21. Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats.
Wu-Wong JR; Li X; Chen YW
J Steroid Biochem Mol Biol; 2015 Apr; 148():202-9. PubMed ID: 25500070
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
23. VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.
Wu-Wong JR; Kawai M; Chen YW; Nakane M
Br J Pharmacol; 2011 Sep; 164(2b):551-60. PubMed ID: 21557735
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
25. Cardiac effect of vitamin D receptor modulators in uremic rats.
Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
[TBL] [Abstract][Full Text] [Related]
26. Hypertension and Organ Damage in Women.
Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
[TBL] [Abstract][Full Text] [Related]
27. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.
Wang AY; Fang F; Chan J; Wen YY; Qing S; Chan IH; Lo G; Lai KN; Lo WK; Lam CW; Yu CM
J Am Soc Nephrol; 2014 Jan; 25(1):175-86. PubMed ID: 24052631
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
Chen B; Kawai M; Wu-Wong JR
Bioorg Med Chem Lett; 2013 Nov; 23(21):5949-52. PubMed ID: 24035340
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
Moradi H; Sica DA; Kalantar-Zadeh K
Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.
Foster MC; Rawlings AM; Marrett E; Neff D; Willis K; Inker LA; Coresh J; Selvin E
Am Heart J; 2013 Jul; 166(1):150-6. PubMed ID: 23816034
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.
Kuznik A; Mardekian J; Tarasenko L
BMC Nephrol; 2013 Jun; 14():132. PubMed ID: 23802885
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
Gansevoort RT; Correa-Rotter R; Hemmelgarn BR; Jafar TH; Heerspink HJ; Mann JF; Matsushita K; Wen CP
Lancet; 2013 Jul; 382(9889):339-52. PubMed ID: 23727170
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies.
van Ballegooijen AJ; Reinders I; Visser M; Brouwer IA
Am Heart J; 2013 May; 165(5):655-64, 664.e1-5. PubMed ID: 23622902
[TBL] [Abstract][Full Text] [Related]
34. Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
Wu-Wong JR; Kawai M; Chen YW; Wessale JL; Huang CJ; Wu MT; Nakane M
Am J Nephrol; 2013; 37(4):310-9. PubMed ID: 23548814
[TBL] [Abstract][Full Text] [Related]
35. Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
Wu-Wong JR; Nakane M; Chen YW
Life Sci; 2013 Feb; 92(2):161-6. PubMed ID: 23261531
[TBL] [Abstract][Full Text] [Related]
36. Improving the efficacy of RAAS blockade in patients with chronic kidney disease.
Lambers Heerspink HJ; de Borst MH; Bakker SJ; Navis GJ
Nat Rev Nephrol; 2013 Feb; 9(2):112-21. PubMed ID: 23247573
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
Thadhani R; Appelbaum E; Pritchett Y; Chang Y; Wenger J; Tamez H; Bhan I; Agarwal R; Zoccali C; Wanner C; Lloyd-Jones D; Cannata J; Thompson BT; Andress D; Zhang W; Packham D; Singh B; Zehnder D; Shah A; Pachika A; Manning WJ; Solomon SD
JAMA; 2012 Feb; 307(7):674-84. PubMed ID: 22337679
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
